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Cerebrospinal fluid pulse pressure amplitude
during lumbar infusion in idiopathic normal
pressure hydrocephalus can predict response to
shunting
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Abstract
Background: We have previously seen that idiopathic normal pressure hydrocephalus (iNPH) patients having
elevated intracranial pressure (ICP) pulse amplitude consistently respond to shunt surgery. In this study we
explored how the cerebrospinal fluid pressure (CSFP) pulse amplitude determined during lumbar infusion testing,
correlates with ICP pulse amplitude determined during over-night ICP monitoring and with response to shunt
surgery. Our goal was to establish a more reliable screening procedure for selecting iNPH patients for shunt
surgery using lumbar intrathecal infusion.
Methods: The study population consisted of all iNPH patients undergoing both diagnostic lumbar infusion testing
and continuous over-night ICP monitoring during the period 2002-2007. The severity of iNPH was assessed using
our NPH grading scale before surgery and 12 months after shunting. The CSFP pulse was characterized from the
amplitude of single pressure waves.
Results: Totally 62 iNPH patients were included, 45 of them underwent shunt surgery, in whom 78% were shunt
responders. Among the 45 shunted patients, resistance to CSF outflow (Rout) was elevated (≥ 12 mmHg/ml/min) in
44. The ICP pulse amplitude recorded over-night was elevated (i.e. mean ICP wave amplitude ≥ 4 mmHg) in 68%
of patients; 92% of these were shunt responders. In those with elevated overnight ICP pulse amplitude, we found
also elevated CSFP pulse amplitude recorded during lumbar infusion testing, both during the opening phase
following lumbar puncture and during a standardized period of lumbar infusion (15 ml Ringer over 10 min). The
clinical response to shunting after 1 year strongly associated with the over-night ICP pulse amplitude, and also
with the pulsatile CSFP during the period of lumbar infusion. Elevated CSFP pulse amplitude during lumbar
infusion thus predicted shunt response with sensitivity of 88 and specificity of 60 (positive and negative predictive
values of 89 and 60, respectively).
Conclusions: In iNPH patients, shunt response can be anticipated in 9/10 patients with elevated overnight ICP
pulse amplitude, while in only 1/10 with low ICP pulse amplitude. Additionally, the CSFP pulse amplitude during
lumbar infusion testing was elevated in patients with elevated over-night ICP pulse amplitude. In particular,
measurement of CSFP pulse amplitude during a standardized infusion of 15 ml Ringer over 10 min was useful in
predicting response to shunt surgery and can be used as a screening procedure for selection of iNPH patients for
shunting.
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Background
The clinical condition normal pressure hydrocephalus
(NPH) incorporates gait disturbance, mental deteriora-
tion and urinary incontinence, combined with enlarged
cerebral ventricles and a normal lumbar cerebrospinal
fluid pressure (CSFP) [1]. Usually no cause is identified,
in which case the condition is denoted idiopathic NPH
(iNPH). Although the pathophysiology of iNPH is dis-
puted [2], previous studies have shown that shunt sur-
gery can be effective, and that clinical improvement can
be sustained for years [3-5].
Hydrodynamic tests, in particular the lumbar infu-
sion test, have been used for selecting patients for sur-
gery, although the literature is very divergent
concerning its role in iNPH [6]. During lumbar infu-
sion testing, the static CSFP can either be monitored
during constant flow infusion, constant pressure infu-
sion or during bolus infusion to the thecal sac. In our
practice, we have for many years used a modification
of the constant rate infusion test originally described
by Katzman [7] for determination of resistance to CSF
outflow (Rout). However, the utility of Rout in selecting
iNPH patients for surgery is controversial [8-13]. On
the other hand, we have found that the ICP pulse (that
is the amplitude of the single cardiac-beat induced ICP
waves) during over-night ICP monitoring is very useful
for predicting shunt response in iNPH [14]. Thus, in
our previous series of 130 shunted iNPH patients,
shunt response was seen in 9 of 10 patients with ele-
vated ICP wave amplitudes but only in 1 of 10 with
low ICP wave amplitudes [15].
With regard to lumbar infusion testing, the various
approaches (e.g. constant flow, constant pressure or
bolus infusion methods) consistently assess the static
and not the pulsatile CSFP. Others [16] and our group
[8,11,17] have reported experiences from assessing the
pulsatile CSFP during lumbar infusion testing. Based on
these experiences, it could be anticipated that determin-
ing the CSFP pulse during lumbar infusion testing
might better characterize the pressure-volume reserve
capacity than the static CSFP. Moreover, successful
assessment of the pulsatile CSFP during lumbar punc-
ture might represent an advantage, given that lumbar
puncture is a low-risk procedure, and more useful in a
clinical neurological setting than continuous ICP moni-
toring. The pulsatile CSFP can be measured during the
opening phase of lumbar puncture, as well as during
lumbar infusion. Thus, our goal with the present study
was to establish a more reliable screening procedure for
selection of iNPH patients for shunt surgery, based on
determining the CSFP pulse amplitude during lumbar
infusion testing. For this purpose, in the present study
we explored how measurement of the pulsatile CSFP
during lumbar infusion testing correlated with the ICP
pulse monitored over-night and with the response to
shunting. To do this we retrieved all lumbar infusion
tests done during diagnostic work-up for iNPH in this
department during the time period 2002-2007. These
infusion tests were stored as continuous CSFP raw data
(originally sampled at 100-200 Hz). In the present study,
these raw data files were re-analyzed; the CSFP pulse
amplitude was determined during the opening phase
after lumbar puncture and also during a period of lum-
bar infusion (standardized as 15 ml infusion over 10
min). All patients had their ICP monitored over-night;
therefore the infusion test results could be related to the




The patient material consisted of all patients being
assessed for iNPH at the Department of Neurosurgery,
Rikshospitalet University Hospital, during the 6-years
period 2002-2007, in whom both over-night ICP moni-
toring and lumbar infusion testing had been done dur-
ing the diagnostic pre-operative work-up. The patients
were referred from local neurological departments based
on their symptoms of gait disturbance, incontinence,
and dementia, combined with radiological
ventriculomegaly.
For diagnostic work-up the patients were hospitalized
for 3 days. Following clinical and radiological assessment
on day 1 (day of admittance), ICP monitoring was done
from day 2 to day 3. The lumbar infusion test was done
on day 3. After discharge from the department on day
3, they returned 1-3 weeks later for surgical treatment
provided this was advocated.
This study was approved by the hospital authority of
Rikshospitalet University Hospital and by the Norwegian
Social Science Data Services. The Regional Committee
for Research Ethics was informed in writing, and had no
objections to the study.
Clinical and radiological assessment
Our diagnostic work-up for iNPH patients has pre-
viously been described [14,15]. In short, based on find-
ings at neurological examination, the severity of clinical
iNPH was graded using our NPH grading scale (scores
ranging from 3-15), which assesses the combined sever-
ity of gait disturbance, urinary incontinence and demen-
tia. The size of the ventricles was assessed using the
linear measure Evan’s index [14].
Diagnostic ICP monitoring and lumbar infusion testing
Diagnostic continuous ICP monitoring was done
through a frontal burr hole prepared under local
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anesthesia. A Codman ICP MicroSensor (Codman,
Johnson & Johnson, Raynham, MA, USA) was placed 1-
2 cm into the brain parenchyma. The ICP monitoring
was done from the evening of day 2 until the morning
of day 3. For each patient we used the over-night ICP
recording from 11 p.m. to 7 a.m., when the patient was
supine in bed.
On the morning day 3, the lumbar infusion test was
done, as previously described [11]. Our strategy repre-
sents a modification of the original Katzman procedure
[7]. The test was performed with the patient in the
supine position by making a midline lumbar puncture
with a 19-gauge needle between the L3 and L4 vertebrae
(one puncture only). The lumbar cerebrospinal fluid
(CSF) pressure was measured continuously using the
Truwave PX-600F Pressure Monitoring Set (Edwards
Life sciences LLC, Irvine, CA, USA), during the opening
phase after lumbar puncture (Po), and during infusion
with a Ringer solution at a standard infusion rate of 1.5
ml/min (fig 1a). The resistance to CSF outflow (Rout)
was calculated as the difference between the plateau
pressure (Pp) and the opening pressure (Po), divided by
infusion rate [11,18].
Surgical treatment
The criteria for surgical treatment during this time per-
iod were based on a combination of clinical and radiolo-
gical observations, and ICP monitoring, as previously
described [15]. The infusion test was considered abnor-
mal when resistance to CSF outflow (Rout) was ≥ 12
mmHg/ml/min. Surgical treatment was implantation of
a ventriculo-peritoneal (VP) shunt: 46 patients received
a HAKIM™ Programmable Valve Shunt System (Cod-
man & Shurtleff, Inc. Medos S.A. CH 2400 Le Locle,
Switzerland), and two patients received a programmable
gravitational shunt (proGAV-Shunt system, Aesculap
Miethke, Tutlingen, Germany.
Follow-up and outcome assessment
Follow-up was done in our out-patient clinic at regular
time intervals, first at three months. As during the pre-
operative examination, the NPH score expressed the
combined severity of gait disturbance, urinary inconti-
nence and dementia. If a patient at some time was
unable to attend the clinic, he or she was interviewed by
phone. The response to shunt surgery was determined
after 12 months. We define an increase ≥ 2 scores on
our NPH scale as representative of clinical improve-
ment, a change which is generally appreciated by the
patients and their families/proxies. Thus, the surgically
treated patients were categorized either as Responders
(change in NPH score ≥ 2) or Non-responders (change
in NPH score < 2), respectively.
Analysis of pulsatile ICP and pulsatile lumbar CSF
pressure
The continuous ICP/CSFP waveforms were stored on a
hospital server (sampling rate 100-200 Hz). A method
[14] implemented in software (Sensometrics software,
dPCom As, Oslo) was used for retrospective analysis of
the CSFP and ICP waveforms. In short, the automatic
algorithm identifies the cardiac-beat induced single pres-
sure waves within the continuous pressure signal. For
each single pressure wave, pulsatility is characterized by
the amplitude [pressure difference (dP) from systolic
maximum to diastolic minimum; fig 1b]. For each con-
secutive six-second (6 s) time window (fig 1b, c), the
method computes mean wave amplitude (representing
the pulsatile pressure), and mean pressure (representing
the static pressure). The 6 s parameter values can be
plotted against time (fig 1a, d), and average values deter-
mined for selected time periods.
The pulsatile ICP was characterized as the average
value of ICP wave amplitude over-night from 11 p.m. to
7 a.m. The pulsatile CSFP was determined both as the
average of CSFP wave amplitude during the opening
phase after lumbar puncture (fig 1d), and also as the
average of CSFP wave amplitude during the standar-
dized infusion time of 10 min, i.e. infusion of 15 ml dur-
ing 10 min at a rate of 1.5 ml/min (fig 1d). We selected
a standardized infusion period of 10 min (corresponding
to a standardized infusion volume of 15 ml) to be able
to compare all the infusion tests.
Statistics
Statistical analyses were performed in SPSS, version 12.0
(SPSS Inc., Chicago, IL, USA). Differences between
groups were determined by one-way ANOVA. Correla-
tions were calculated using bivariate analysis, with deter-
mination of Spearman correlations. Significance was
accepted at the 0.05 level.
Results
Patients
During the period 2002-2007, a total of 214 iNPH
patients underwent diagnostic ICP monitoring as part of
pre-operative work-up in the Department of neurosur-
gery. A subgroup of 62 iNPH patients also underwent
lumbar infusion testing the day following over-night ICP
monitoring (Table 1). Median age of the total material
was 72 years; their symptoms had lasted median 2.8
years (Table 1).
Results of diagnostic ICP monitoring and lumbar infusion
testing
Diagnostic ICP monitoring caused minor complications
in 4 of 62 patients (6.5%), which only included subcuta-
neous wound infections that were treated with
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Figure 1 Analysis of lumbar infusion tests: (a) a plot showing our conventional method of performing a lumbar infusion test, using
constant-rate infusion at 1.5 ml/min of Ringer solution. The plot of mean CSFP against time incorporates the period before infusion
(opening pressure; Po), and during the infusion period (infusion rate of 1.5 ml/min). The plateau pressure (Pp) is indicated. The resistance to CSF
outflow (Rout) is calculated as (Pp - Po)/infusion rate. Two 6 s time windows of the continuous CSFP signal from (b) the start and (c) the
termination of the infusion test are indicated, illustrating the single CSFP pulse waves. (d) Plot of mean CSFP pulse amplitude against time,
indicating the period after lumbar puncture and before infusion (opening phase), and the 10 min period during the infusion. For comparison
between patients we compared the CSFP pulse amplitude during the first 10 min of infusion.
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antibiotics without sequels. The lumbar infusion tests
caused no complications.
The static ICP was normal in all patients (mean ICP
7.6 ± 4.8 mmHg). During over-night ICP monitoring
(11 p.m. to 7 a.m.) the pulsatile ICP was elevated (i.e.
mean ICP wave amplitude ≥ 4 mmHg) in 42 of 62
patients (68%; Table 2). The pulsatile CSFP was elevated
in the sub-group with over-night pulsatile ICP (fig 2);
this was seen during the opening phase after lumbar
puncture (fig 2a), but was even more evident during the
period of lumbar infusion (fig 2b). Thus, among 42
patients with elevated pulsatile ICP over-night (ICP
wave amplitude ≥ 4 mmHg), the pulsatile CSFP was low
(CSFP wave amplitude < 2 mmHg) in 17 subjects during
the opening phase of lumbar puncture (fig 2a), while
pulsatile CSFP was low (CSFP wave amplitude < 4
mmHg) in only 5 subjects during lumbar infusion (fig
2b). The numbers are further detailed in Table 2.
Clinical response to shunting related to the diagnostic
ICP and infusion testing
Forty-five of the 62 patients were shunted, in whom 35
(78%) were shunt responders (Table 1). Major complica-
tions to shunt surgery were seen in 18% of patients
(chronic subdural haematoma in 7%, shunt infection in
2%, visual failure in 2%, and shunt failure in 7%). Minor
complications (headache, abdominal pain, dizziness)
were seen in 13%.
Among the 45 patients being shunted, Rout ≥ 12
mmHg/ml/min was seen in 44 patients. Moreover, of
these 44 patients, 35 (79.5%) were shunt responders,
whereas nine (20.5%) were non-responders. There was a
weak, though significant, correlation between Rout and
change in NPH score (i.e. clinical improvement) 12
months after shunting (Spearman correlation 0.31; P =
0.04; one way ANOVA; data not shown).
When correlating the clinical improvement 12 months
after shunting (change in NPH score) with the CSFP
pulse, we found a highly significant correlation with the
ICP pulse amplitude recorded over-night (Spearman
correlation 0.58; P < 0.001; fig 3a). The clinical improve-
ment after 12 months was not significantly correlated
with the CSFP pulse measured during the opening
phase after lumbar puncture (Spearman correlation, fig
3b). On the other hand, we found a significant correla-
tion between the change in NPH score after 12 months
and the CSFP pulse measured during lumbar infusion
(15 ml over 10 min) (Spearman correlation 0.47; P =
0.002; fig 3c). These observations are further illustrated
in fig 4. The shunt responders and non-responders were
best differentiated by the over-night ICP monitoring (fig
4a), but were also differentiated by the CSFP pulse dur-
ing the opening phase after lumbar puncture (fig 4b)
and more so by the pulse during infusion (fig 4c).
The prediction of shunt response from results of ICP
monitoring or lumbar infusion testing is presented in
Table 3. The data show high positive predictive values
(PPV) and negative predictive values (NPV) for ICP
pulse amplitude recorded over-night, and also for the
CSFP pulse during lumbar infusion.
Discussion
The main observation of this study is that the CSFP
pulse amplitude determined during lumbar infusion
testing showed good correlation with the ICP pulse
amplitude recorded over-night, and also with the clinical
response to shunting in iNPH. The data support our
hypothesis that determining pulsatile CSFP during







Number 62 10 35
Age (yrs) 72 (37 -
85)
68 (47 - 81) 72 (47 - 81)






3 (1 - 10) 3 (1 - 8)
NPH score (15-3) 9 (4 - 14) 11 (6 - 14) 9 (4 - 13)
Radiology
Evan’s index 0.4 (0.3 -
0.5)
0.4 (0.3 - 0.5) 0.4 (0.3 -
0.5)
Table 2 The CSFP pulse during lumbar puncture versus ICP pulse during over-night ICP monitoring
Over-night ICP monitoring* Lumbar puncture
ICP wave amplitude CSFP wave amplitude during opening phase CSF wave amplitude during lumbar infusion
< 2 mmHg ≥ 2 mmHg < 4 mmHg ≥ 4 mmHg
< 4 mmHg (n = 20) 17 3 12 8
≥ 4 mmHg (n = 42) 17 25 5 37
Statistics Sensitivity = 60; Specificity = 85
PPV = 89; NPV = 50
Sensitivity = 88; Specificity = 60
PPV = 82; NPV = 71
*Mean ICP wave amplitude from the period 11 p.m. to 7 a.m.
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Figure 2 Scatter plots of CSFP wave amplitude during the opening period and during lumbar infusion for the two categories of over-
night pulsatile ICP (mean ICP wave amplitude either < 4 mmHg or ≥ 4 mmHg during the period 11 p.m. to 7 a.m.) a) Shows the
pulsatile CSFP (mean CSFP wave amplitude) during the opening phase after lumbar puncture, and (b) during the phase of lumbar
infusion (15 ml over 10 min; 1.5 ml/min). Dotted lines denote different targets for CSFP wave amplitude during the opening period and
during lumbar infusion. Significant differences between groups were tested with one-way ANOVA.
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Figure 3 Graphs showing the correlation between changes in
NPH Score one year after shunt surgery and (a) ICP wave
amplitude during over-night ICP monitoring, (b) CSFP wave
amplitude during the opening phase after lumbar puncture,
and (c) CSFP wave amplitude during the phase of lumbar
infusion (15 ml over 10 min; 1.5 ml/min).
Figure 4 Scatter plots of mean CSFP wave amplitude for shunt
response categories non-responder and responder during (a)
over-night ICP monitoring, (b) during the opening phase after
lumbar puncture, and (c) during the phase of lumbar infusion.
Dotted lines denote cut off targets for the pulsatile pressure (wave
amplitude). The pulse amplitude during the opening phase of
lumbar puncture was not as good a predictor for shunt response as
the amplitude during overnight monitoring and during lumbar
infusion. Significant differences between responders and non-
responders are shown (one-way ANOVA).
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lumbar infusion can be useful as a screening procedure
for selection of iNPH patients for shunting.
Patients
We have previously reported our entire experience of
managing iNPH patients using diagnostic ICP monitor-
ing in the pre-operative work-up during the period
2002-2007 [15]. The present subgroup of 62 iNPH
patients managed during the same time period repre-
sented the patients that also underwent lumbar infusion
testing on day 3. The reason for doing lumbar infusion
testing in these patients was that lumbar infusion testing
has been done since the 1980’s in this department, and
thus represented the traditional management. Therefore,
we considered how this subgroup compared with our
entire cohort of iNPH patients. The present group of 62
patients compared well with our entire cohort during
this time period regarding age, sex, symptom duration,
severity of symptoms and ventricular size (Table 1) [15].
Moreover, in our entire cohort of 130 shunted iNPH
patients, 79% were shunt responders [15], as compared
to 78% of 45 shunted iNPH patients in the present
study. The present material is therefore representative of
our entire experience of managing iNPH. In compari-
son, McGirth et al. [4], using 3-days external lumbar
drainage (ELD) and positive finding of A- or B-waves on
spinal puncture, found in 132 patients a long term shunt
response rate of 75%. Moreover, using gait improvement
after 3-days ELD to aid selection for surgery, Marmarou
et al. [3] reported clinical improvement in 76 (91%) of
84 patients.
Overnight pulsatile ICP versus pulsatile CSFP during
lumbar infusion testing
Based on our experience of diagnostic ICP monitoring
in 214 iNPH patients [15], we categorized pulsatile ICP
as being elevated when ICP wave amplitude is ≥ 4
mmHg during over-night monitoring. Thus, among 130
shunted iNPH patients, 93% with elevated ICP pulse (i.e.
ICP wave amplitude ≥ 4 mmHg during over-night moni-
toring) were shunt responders whereas only 10% with
low ICP pulse (i.e. ICP wave amplitude < 4 mmHg over-
night) responded to shunting [15]. In the present group,
68% of patients had elevated ICP pulse.
The present dataset clearly showed that pulsatile CSFP
was elevated in those with elevated over-night ICP
pulse. This was most evident during the period of lum-
bar infusion, as compared to the opening phase after
lumbar puncture (fig 2; Table 2). Examining simulta-
neous measurements of lumbar CSFP pulse and intra-
cranial ICP pulse during lumbar infusion testing, we
have previously shown in 35,532 CSFP/ICP single wave
pairs that the lumbar CSFP wave amplitudes are about 2
mmHg below the simultaneous cranial ICP wave ampli-
tudes [17]. Thus, from this experience, we categorized
ICP wave amplitudes ≥ 4 mmHg as indicative of ele-
vated pulsatile ICP [15], and lumbar CSFP wave ampli-
tude ≥ 2 mmHg as indicative of elevated pulsatile CSFP
[8,17].
One explanation for this discrepancy between the
intracranial and intraspinal compartments is the differ-
ence in compliance (i.e. pressure-volume reserve capa-
city) between the compartments. This assumption is
further illustrated in fig 5; the pressure-volume curve of
the intraspinal compartment is moved to the right as
compared to the curve of the intracranial compartment,
indicative of higher compliance in the intraspinal than
the intracranial compartment. A methodological draw-
back relates to the fact that the pulsatile CSFP during
lumbar infusion testing was measured through the same
needle as the infusion. Therefore the pulsatile CSFP
during infusion might be slightly increased due to the
resistance of the lumbar needle at the infusion rate of
1.5 ml/min. Measurements from a second needle might
prevent this effect, and give slightly lower pulsatile CSFP
values. However, the impact of this effect is probably
minor. Thus, simultaneous measurements of pulsatile
ICP and lumbar pulsatile CSFP during lumbar infusion
showed that the lumbar CSFP pulse amplitudes were
about 2 mmHg below the ICP pulse amplitudes both
before and during the infusion [17].
In the present study, we solely focused on the pulsatile
pressures. In line with our previous experience [15],
over-night static ICP was normal in these patients
Table 3 Number of shunt responders/non-responders depending on results of lumbar puncture or ICP monitoring






< 2 mmHg ≥ 2 mmHg < 4 mmHg ≥ 4 mmHg < 4 mmHg ≥ 4 mmHg
Responder (n = 35) 13 22 4 31 1 34
Non-Responder (n = 10) 8 2 6 4 7 3
Statistics Sensitivity = 63; Specificity = 80
PPV = 92; NPV = 38
Sensitivity = 88; Specificity = 60
PPV = 89; NPV = 60
Sensitivity = 97; Specificity = 70
PPV = 92; NPV = 88
* Mean ICP wave amplitude from the period 11 p.m. to 7 a.m. PPV = Positive predictive value; NPV = Negative predictive value.
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(hence the term normal pressure hydrocephalus). Others
have previously examined differences in the static pres-
sures between intraspinal and intracranial compart-
ments. Several authors have found that the short-lasting
opening CSFP measured during the opening phase of
lumbar puncture (opening pressure) did not relate well
to ICP recorded over-night [17,19,20]. Others found
lumbar mean CSFP to agree with the ICP across a large
pressure interval [21]. The reason for the discrepancy is
that the static pressure depends on the baseline level
and zero calibration since the static pressure refers to
the difference between the atmospheric pressure and the
intra-compartment pressure [22,23]. The pulsatile pres-
sure, characterized by the wave amplitude, on the other
hand, refers to the intra-signal difference between the
diastolic and systolic pressures (fig 1), thus being inde-
pendent of the baseline pressure level [22,23]. We have
previously shown that the two sensors used for pressure
monitoring in this study are equivalent for pulse pres-
sure wave analysis; comparing a total of 218,589 single
pressure wave pairs from the intracranial compartment
from these two pressure sensors revealed a difference in
pulse pressure amplitude of only 0.13 mmHg (95% con-
fidence interval 0.12 -0.13 mmHg) [23].
Clinical response to shunting related to the diagnostic
ICP and infusion testing
Among those 37 patients with elevated ICP pulse over-
night (i.e. mean ICP wave amplitude ≥ 4 mmHg; time
period 11 p.m. - 7 a.m.), 34 (92%) were shunt
responders, while among those eight with low ICP pulse
overnight (i.e. mean ICP wave amplitude > 4 mmHg;
time period 11 p.m. - 7 a.m.) only one (13%) responded
to shunting (Table 3). These numbers compare with our
entire series of shunted iNPH patients during this same
time period (2002-2007) [15].
During lumbar infusion testing, our standard approach
has been to determine resistance to CSF outflow (Rout).
The cut-off value for considering Rout pathologically ele-
vated varies in the literature. According to our routine,
we have considered Rout ≥ 12 mmHg/ml/min as abnor-
mal [6,12]. Therefore, among our 45 shunted iNPH
patients, Rout ≥ 12 mmHg/ml/min was seen in all but
one patient. Among the resulting 44 patients, 35 (80%)
were shunt responders. In general, the role of Rout in
predicting shunt response is still highly disputed
[6,8-10,13]. Based on our earlier experience with deter-
mination of Rout [8,11], we have now discontinued using
the Rout for the purpose of selecting iNPH patients for
shunting.
In this cohort, we found a highly significant correla-
tion between overnight pulsatile ICP and the degree of
clinical improvement seen 12 months after shunting (fig
3a). The correlation between Rout and clinical improve-
ment was weaker, though it reached significance. These
observations compare with our previous experience
[8,11,15]. A new observation here was that the CSFP
pulse amplitude measured during lumbar infusion (15
ml over 10 min) correlated better with clinical improve-
ment after shunting (fig 3c). This latter observation
Figure 5 Assessments of intracranial compliance and lumbar compliance during lumbar infusion. This diagram illustrates the intracranial
and lumbar pressure-volume curves and the relationship to the pulsatility parameters. Under normal physiologic conditions with high
intracranial compliance, ICP wave amplitude is correspondingly small. As intracranial compliance decreases (steep part of the pressure-volume
curve), the brain behaves increasingly like a linear elastance and so variations in intracranial volume correlate increasingly well with changes in
ICP wave amplitude, thus the steepness of the pressure-volume curve accounts for large-amplitude ICP waveforms. The cranial pressure-volume
curve is left of the lumbar pressure-volume curve, illustrating that compliance is higher in the lumbar compartment.
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compares with recently reported observations, focusing
on the distribution of the CSFP pulse during lumbar
infusion testing [8]. It should be noted that prior to
shunting the Rout and not the CSFP pulse was used to
select patients for shunt surgery. As shown in Table 3,
clinical response to shunting was best predicted by
over-night ICP monitoring, in line with previous obser-
vations [15]. The most important observation of this
study is that clinical shunt response was also predicted
by the CSFP pulse during lumbar infusion (Table 3).
Thus, when CSFP wave amplitude was ≥ 4 mmHg dur-
ing lumbar infusion of 15 ml over 10 min, clinical
response to shunting was predicted with a sensitivity of
88 and specificity of 60 (PPV 89; NPV 60).
Taken together, the present results suggest that deter-
mining CSFP pulse amplitude during lumbar infusion
testing can be useful as a screening procedure for selec-
tion of patients to shunt surgery. An advantage of lum-
bar infusion testing, as compared to over-night ICP
monitoring, is that the procedure is a low cost and low
threshold approach with few complications that is
widely used. Moreover, determining the CSFP pulse was
more useful than the Rout determination.
Measuring pulsatile CSFP during lumbar infusion versus
intracranial compliance
Figure 5 provides a tentative explanation of what is
being tested while monitoring pulsatile CSFP during
lumbar infusion. We assume that the CSFP pulse pro-
vides an indirect measure of the compliance (pressure-
volume reserve capacity) of the intraspinal compart-
ment. When the compliance is being reduced, the
amplitudes (dP) are increasing [24,25]. The wave ampli-
tude (dP) is the pressure response to the volume change
caused by each cardiac contraction, which in the intra-
cranial compartment is about 1 ml [26]. During lumbar
infusion the compliance is being artificially reduced
(moving to the right on the pressure-volume curve).
When compared to the cranial pressure-volume curve,
the spinal pressure-volume curve is shifted to the right
because compliance in the spinal compartment is higher
than in the intracranial compartment [17]. For this rea-
son it is necessary to infuse fluid intrathecally to reach
the same amplitude values in the lumbar compartment
as in the intracranial compartment. Although the wave
amplitudes do not measure compliance directly, they are
related to compliance [27] and elevated ICP pulse is
associated with reduced intracranial compliance [28].
An important effect of shunting is improved compliance
and this is why elevated ICP pulse measured during
over-night ICP monitoring and also during lumbar infu-
sion, accurately predicts the shunt response in these
patients (Table 3).
Conclusions
Taken together, determining CSFP pulse amplitude dur-
ing lumbar infusion in this cohort of iNPH patients was
useful for predicting shunt response. The data suggest
that the approach can be used for screening of iNPH
patients for shunt surgery.
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